<p>Around the world, the multidrug resistant and pan-resistantfungus <em>Candida auris</em> has caused outbreaks in healthcare systems. While it is now highlighted by CDC as an urgent threat, only six years ago there were no reports of resistant <em>C. auris</em> strains that were able to spread easily between patients. These infections are challenging to treat a with 5% — 10% of colonized patients going on to develop invasive infections. This episode will cover how these outbreaks have impacted patients, healthcare systems, and continued efforts to better understand and slow the impact of these infections.</p>
<p><strong>Guests:</strong></p>
<p><strong>Tom M Chiller</strong> - Chief, Mycotic Diseases Branch, Centers for Disease Control and Prevention</p>
<p><strong>Andrew Jacobs</strong> - Reporter, Health and Science desk, The New York Times</p>
<p><strong>Bhavarth Shukla</strong> - Associate Professor, Division of Infectious Diseases, University of Miami</p>
<p><strong>Materials Mentioned in this Episode</strong></p>
<p><a href="https://www.nytimes.com/2019/04/06/health/drug-resistant-candida-auris.html">A Mysterious Infection, Spanning the Globe in a Climate of Secrecy</a>, Matt Richtel and Andrew Jacobs, The New York Times</p>
<p><a href="https://www.cdc.gov/antimicrobial-resistance/data-research/threats/covid-19.html">2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance</a>, Centers for Disease Control and Prevention</p>
Podden och tillhörande omslagsbild på den här sidan tillhör
CIDRAP. Innehållet i podden är skapat av CIDRAP och inte av,
eller tillsammans med, Poddtoppen.
